Director/PDMR Shareholding

Savills

29/04/2026 13:23

RNS Number : 4489C

Savills PLC

29 April 2026

 

The following amendment has been made to the Director/PDMR Shareholding announcement released on 29 April 2026 at 13:23:26 under RNS #4417C:

 

The date of the vesting (28 April 2026) of Deferred Share Awards has been added to the introductory paragraph.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

SAVILLS PLC (THE "COMPANY")

TRANSACTION IN SHARES BY DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS)

 

Vesting of Deferred Share Awards

 

Awards over ordinary shares of the Company under the Company's Deferred Share Plans have become unconditional in all respects following the end of their Deferred Period.  In satisfaction of the Awards, the Trustees of the Group's Employee Benefit Trusts have effected the transfer of shares on 28 April 2026, following the settlement of associated tax liabilities through the sale of shares, to Directors and PDMRs of the Company as follows:

 

Director/ PDMR
Number of shares transferred
Number of shares disposed to cover tax liabilities associated with award vesting
Shareholding following this notification
Shareholding as a % of issued share capital
Simon Shaw (Director)
48,468
43,468
(shares sold to cover tax liabilities associated with award vesting only)
276,793
0.19%
Martin Fidden (PDMR)
8,664
-
34,046
0.02%
Alex Jeffrey (PDMR)
53,143
-
292,074
0.20%
Chris Lee (PDMR)
9,774
8,710
(shares sold to cover tax liabilities associated with award vesting only)
133,311
0.09%
Raymond Lee (PDMR)
35,671
-
211,852
0.14%
David Lipson (PDMR)
30,333
-
175,760
0.12%
James Sparrow (PDMR)
42,767
38,106
(shares sold to cover tax liabilities associated with award vesting only)
170,884
0.12%

 

The share price on disposal of all shares was £8.405 per share.

 

 

 

 

Grant of Deferred Share Awards

 

The Company announces that on 28 April 2026 the grant of the share-based element of 2025 profit share awards has been made under The Savills Deferred Share Bonus Plan to Directors and PDMRs as follows:

 

Director/ PDMR
Number of shares subject to The Savills Deferred Share Bonus Plan awarded to the Director/ PDMR on 28 April 2026
Simon Shaw (Director)
111,077
Chris Lee (PDMR)
22,155
David Lipson (PDMR)
9,105
James Sparrow (PDMR)
63,832

These awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased during the Deferred Period to reflect final and interim dividends declared during the Deferred Period.

 

The Company also announces that on 28 April 2026 the grant of an award has been made under The Savills Deferred Share Plan (No.2 Plan) to the following PDMR:

PDMR
Number of shares subject to The Savills Deferred Share Plan (No.2 Plan) awarded to the PDMR on 28 April 2026
Martin Fidden (PDMR)
119,758

13% of the above award has a Deferred Period of two years

51% of the above award has a Deferred Period of three years

36% of the above award has a Deferred Period of four years

70% of the award with a Deferred Period of three years and 100% of the award with a Deferred Period of four years is subject to the satisfaction of performance criteria relating to the financial performance of the Savills Asia Pacific ex-Greater China business over 2025 to 2027 (inclusive).

All tranches of the award are subject to rolled-up dividend shares whereby the number of shares awarded will be increased during the Deferred Periods to reflect final and interim dividends declared during the Deferred Periods.

 

The Company also announces that on 28 April 2026 the grant of an award has been made under The Schedule to The Savills Deferred Share Plan (No.2 Plan) to a PDMR based in the United States of America as follows:

 

PDMR
Number of shares subject to the Savills Deferred Share Plan awarded to the PDMR on 28 April 2026
David Lipson (PDMR)
44,214

One-third of Mr Lipson's award will vest on each of the three anniversaries subsequent to the date of grant subject to continued employment and performance. The award is subject to rolled-up dividend shares whereby the number of shares awarded will be increased during the Deferred Period to reflect final and interim dividends declared during the Deferred Periods.

 

Resulting beneficial interests under The Savills Deferred Share Bonus Plan and The Savills Deferred Share Plan (No.2 Plan) further to the above notifications are as follows:

Director/ PDMR
Resulting beneficial interest under The Savills Deferred Share Bonus Plan and The Savills Deferred Share Plan (No.2 Plan)
Simon Shaw (Director)
237,302
Martin Fidden (PDMR)
65,870
Alex Jeffrey (PDMR)
75,287
Chris Lee (PDMR)
48,348
David Lipson (PDMR)
105,062
James Sparrow (PDMR)
138,914

 

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.
Details of the Director/ PDMR
(a)
Name
1. Simon Shaw
2. Martin Fidden
3. Alex Jeffrey
4. Chris Lee
5. Raymond Lee
6. David Lipson
7. James Sparrow
2.
Reason for the notification
(a)
Position/ status
1. Group Chief Executive/ Director
2. Chief Executive Officer - Asia Pacific (ex-Greater China)/ PDMR
3. Chief Executive Officer - Savills Investment Management/ PDMR
4. Group Legal Director & Company Secretary/ PDMR
5. Chief Executive - Hong Kong, Macau and Greater China/ PDMR
6. Chief Executive Officer - Savills North America/ PDMR
7. Chief Executive Officer - UK & EMEA/ PDMR
(b)
Initial notification/ Amendment
Initial notification
3.
Details of the issuer
(a)
Name
Savills plc
(b)
LEI
213800WXICGMBWHTA933
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)
Description of the Financial Instrument
Savills plc Ordinary Shares of 2.5p each
(b)
Identification code of the Financial Instrument
GB00B135BJ46
(c)
Nature of the transaction
1) Vesting of awards under the Company's Deferred Share Plans and sale of shares to cover tax liabilities associated with award vesting only
2) Grant of awards over Ordinary Shares in accordance with the Company's Deferred Share Plans
(d)
Price(s) and volume(s)
Price(s)
Volume(s)
1)
Acquisition
£nil per share
Disposal (to cover tax liabilities associated with award vesting only)
£8.405 per share
1. 92,253
2. 8,664
3. 53,143
4. 18,484
5. 35,671
6. 30,333
7. 80,873
1. 43,468
2. n/a
3. n/a
4. 8,710
5. n/a
6. n/a
7. 38,106
2)
£nil per share
1. 111,077
2. 119,758
3. n/a
4. 22,155
5. n/a
6. 53,316
7. 63,832
(e)
Aggregated information
- Aggregated volume
- Price
N/A
(f)
Date of the transaction
28 April 2026
(g)
Place of the transaction
Vesting of awards - Outside a trading venue
Sale of shares to cover tax liabilities associated with award vesting only - London Stock Exchange
Grant of awards - Outside a trading venue

 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

 

29 April 2026      

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHUKRSRNUUSUAR